The Relationship between Acute Dyskinesia with a Single Dose of Methylphenidate and Recent Risperidone Discontinuation in a Child with Attention-Deficit/Hyperactivity Disorder
Restricted accessLetterFirst published online May, 2015
The Relationship between Acute Dyskinesia with a Single Dose of Methylphenidate and Recent Risperidone Discontinuation in a Child with Attention-Deficit/Hyperactivity Disorder
AmanMG, BinderC, TurgayA: Risperidone effects in the presence/absence of psychostimulant medicine in children with ADHD, other disruptive behavior disorders, and subaverage IQ. J Child Adolesc Psychopharmacol, 14:243–254, 2004.
2.
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 5th ed. Washington, DC: American Psychiatric Association; 2013.
BalazsJ, DallosG, KeresztenyA, CzoborP, GadorosJ: Methylphenidate treatment and dyskinesia in children with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol, 21:133–138, 2011.
5.
ConnorDF: Stimulants and neuroleptic withdrawal dyskinesia. J Am Acad Child Adolesc Psychiatry, 37:247–248, 1998.
6.
GaraL, RobertsW: Adverse response to methylphenidate in combination with valproic acid. J Child Adolesc Psychopharmacol, 10:39–43, 2000.
7.
HollisCP, ThompsonA: Acute dyskinesia on starting methylphenidate after risperidone withdrawal. Pediatr Neurol, 37:287–288, 2007.
8.
LipkinPH, GoldsteinIJ, AdesmanAR: Tics and dyskinesias associated with stimulant treatment in attention-deficit hyperactivity disorder. Arch Pediatr Adolesc Med, 148:859–861, 1994.
9.
SabuncuogluO: Risperidone-to-methylphenidate switch reaction in children: Three cases. J Psychopharmacol, 21:216–219, 2007.
10.
SeneckyY, LobelD, DiamondGW, WeitzR, InbarD: Isolated orofacial dyskinesia: A methylphenidate-induced movement disorder. Pediatr Neurol, 27:224–226, 2002.
11.
SilvestriS, SeemanMV, NegreteJC, HouleS, ShammiCM, RemingtonGJ, KapurS, ZipurskyRB, WilsonAA, ChristensenBK, SeemanP: Increased dopamine D2 receptor binding after long-term treatment with antipsychotics in humans: A clinical PET study. Psychopharmacology (Berl), 152:174–180, 2000.
12.
VlesJS, FeronFJ, HendriksenJG, JollesJ, van KroonenburghMJ, WeberWE: Methylphenidate down-regulates the dopamine receptor and transporter system in children with attention deficit hyperkinetic disorder (ADHD). Neuropediatrics, 34:77–80, 2003.
13.
WaughJL: Acute dyskinetic reaction in a healthy toddler following methylphenidate ingestion. Pediatr Neurol, 49:58–60, 2013.
